Loading clinical trials...
Loading clinical trials...
To evaluate the safety, efficacy and tolerability of brexpiprazole (with placebo) as monotherapy or combination therapy with Zoloft (sertraline) in adults with PTSD.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
NCT05674617 · Stress Disorders, Post-Traumatic; Mental Disorders
NCT04793776 · Stress Disorders, Post-Traumatic, Aggression, and more
NCT06000475 · Stress Disorders, Post-Traumatic
NCT05889741 · Stress Disorders, Post-Traumatic
NCT03887559 · Stress Disorders, Post-Traumatic, Mental Disorders, and more
Investigational Site
Tuscaloosa, Alabama
Investigational Site
Phoenix, Arizona
Investigational Site
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions